HSTM Stock Tickeron detected bearish Stock Pattern: Head-and-Shoulders Top HSTM on January 30, 2024, netting in a 5.30% gain over 1 month

GET DAILY SIGNALS

Get AI intraday signals

HSTM - HealthStream

Ticker: HSTM

Company: HealthStream

Gain from shortening: +5.3%

Confirmed: 01/30/24

Succeeded: 03/14/24

Total length: 45 days

HSTM sees MACD Histogram crosses below signal line

HSTM saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 08, 2024. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 44 instances where the indicator turned negative. In of the 44 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Technical Analysis (Indicators)

Bearish Trend Analysis

HSTM moved below its 50-day moving average on October 10, 2024 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HSTM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

HSTM broke above its upper Bollinger Band on October 02, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Momentum Indicator moved above the 0 level on October 08, 2024. You may want to consider a long position or call options on HSTM as a result. In of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 10-day moving average for HSTM crossed bullishly above the 50-day moving average on September 25, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HSTM advanced for three days, in of 318 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 213 cases where HSTM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

Tickeron has a negative outlook on this ticker and predicts a further decline by more than 4.00% within the next month with a likelihood of 64%.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HSTM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.325) is normal, around the industry mean (30.829). P/E Ratio (52.280) is within average values for comparable stocks, (161.895). Projected Growth (PEG Ratio) (4.189) is also within normal values, averaging (2.738). Dividend Yield (0.004) settles around the average of (0.083) among similar stocks. P/S Ratio (2.874) is also within normal values, averaging (56.664).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HSTM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.